NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/15/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6,031.76 mln
Float19.53 mln
Earnings Date08/11/2026
EPS
7.46
Stretched
P / E
39.71
Overvalued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-3.59
Highly reliable
1-Year Forecast
298
Fairly priced
Relative Strength
21
/ 100
Significantly lagging
Business Description
Ligand Pharmaceuticals is a Florida-based biopharmaceutical company founded in 1987 that builds revenue by licensing a broad portfolio of drug assets to partners around the world rather than selling medicines directly to patients. Its portfolio spans a wide range of medical needs, including cancer, infectious disease, bone health, diabetes, and rare conditions, with partner products already approved and generating royalties alongside a pipeline of drugs still in development. This business model allows Ligand to earn income from multiple revenue streams while sharing the costs and risks of bringing new treatments to market.